Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Galera reports updated phase I/II study data on GC-4419 in locally advanced pancreatic cancer

April 29, 2021

NFX1-123 as a promising new therapeutic target in cancer

April 29, 2021

G1 Therapeutics initiates registrational study of Cosela in mTNBC

April 29, 2021

ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC

April 29, 2021

Pfizer details development of clinical PRMT5 inhibitor candidate PF-06939999

April 29, 2021

Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors

April 29, 2021

Kainos Medicine presents new IRAK-4 inhibitors

April 29, 2021

New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical

April 29, 2021

Haihe starts first-in-human study of HH-30134 in advanced solid tumors

April 29, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...